Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Entrepreneurship
  • General
  • News
  • Startups

Tesla’s Former Energy Product Chief Is Now A Rival Thanks To $300M Funding Round

By Chris Katje
August 25, 12:49 PM
Kunal Girotra, the former head of energy products at Tesla Inc. (NASDAQ: TSLA), has launched a new company to take on the electric vehicle manufacturer and one of its products.

GNRC

Read More
8 minute read
  • Biotech
  • Cannabis
  • General
  • Health Care
  • Markets
  • Psychedelics

Is Ibogaine A Safe And Effective Treatment For Addictions?

By El Planteo
August 25, 12:40 PM
By Santiago Federico Richetti via El Planteo.

NUMIF

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • News

Medtronic Recalls HeartWare HVAD System Batteries For Electrical Faults

By Vandana Singh
August 25, 12:38 PM
Medtronic Plc (NYSE:MDT) is recalling HeartWare HVAD System batteries because they may experience electrical faults that cause the system to fail…

MDT

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report

By Vandana Singh
August 25, 12:36 PM
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world. FDA approved Tpoxx for smallpox in 2018. 

BVNKF

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer’s COVID-19 Pill Benefited Only Older Adults, New Israel-Based Study Shows

By Vandana Singh
August 25, 12:29 PM
According to a new observational study published in the New England Journal of Medicine, Pfizer Inc's (NYSE: PFE) COVID-19 treatment, Paxlovid, only worked among patients 65 years of age or older, with 

PFE

Read More
1 minute read
  • General
  • News
  • Politics

U.S. Military Aircraft Lands At Taipei’s Downtown Songshan Airport

By Benzinga Newsdesk
August 25, 11:47 AM
-Reuters

EWT

Read More
1 minute read
  • General
  • Legal
  • News
  • Politics

U.S. FCC Launching Investigation Into Mobile Carriers’ Use Of Customer Geolocation Data

By Benzinga Newsdesk
August 25, 11:32 AM
-Agency Statement

T

Read More
1 minute read
  • General
  • News
  • Politics

‘New iPhones to boost 4Q22 handset sales in Taiwan’ -DigiTimes Alert

By Benzinga Newsdesk
August 25, 11:00 AM
Apple with its iPhone 13 series was able to grab a nearly 52% share of the total handset unit sales in Taiwan in October 2021 alone. The upcoming iPhones are expected to boost Taiwan's handset sales starting in

AAPL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Small Cap

Dynavax’s Adjuvant Based COVID-19 Shot Shows Robust Immune Response, Safety In Younger Populations

By Vandana Singh
August 25, 10:31 AM
Hong Kong-listed Clover Biopharmaceuticals Ltd announced data from a global Phase 2/3 trial evaluating its COVID-19 vaccine candidate, SCB-2019, in adolescents (aged 12 to 17 years). 

DVAX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

With Sandoz Spinoff, Novartis Slams Brakes On Huntington’s Trial

By Vandana Singh
August 25, 10:12 AM
Novartis AG (NYSE: NVS) suspended dosing in a Huntington's disease study because early signs of side effects were seen in some participants in the trial.

NVS

Posts pagination

Previous 1 … 2,195 2,196 2,197 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service